Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis

Background Myocarditis attributable to immune checkpoint inhibitor (ICI) therapy is a potentially fatal immune‐related adverse event. Limited data have suggested an association between baseline and on‐treatment absolute lymphocyte count (ALC) and neutrophil/lymphocyte ratio (NLR) and the development...

Full description

Bibliographic Details
Main Authors: Zsofia D. Drobni, Amna Zafar, Leyre Zubiri, Daniel A. Zlotoff, Raza M. Alvi, Charlotte Lee, Sarah Hartmann, Hannah K. Gilman, Alexandra‐Chloe Villani, Anju Nohria, John D. Groarke, Ryan J. Sullivan, Kerry L. Reynolds, Lili Zhang, Tomas G. Neilan
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
immune checkpoint inhibitor
lymphocyte
myocarditis
oncology
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.018306

Similar Items

Similar Items